Item type:Thesis, Open Access

Multizentrische Therapieoptimierungsstudie zum Einsatz von Docetaxel (Taxotere) und Mitoxantron (Novantron) in der Therapie des hormonrefraktären Prostatakarzinoms

Thumbnail Image

Files

dkb.pdf (673.11 KB)

Date

2009-03-03

Authors

Publisher

Philipps-Universität Marburg
DOI

Supervisors

Abstract

Our studie is a multicenter phase II trial with Docetaxel and mitoxantron in the therapie of hormone refractory prostate carcinom.

Review

Metadata

Contributors
Supervisor:
Dates
Created: 2008Issued: 2009-03-03Updated: 2011-08-10
DOI
https://doi.org/10.17192/z2009.0026
Faculty
Medizin
Publisher
Philipps-Universität Marburg
Language
ger
Data types
DoctoralThesis
Keywords
ChemotherapyQuality of lifeProstate carcinom
DFG-subjects
DocetaxelChemotherapieHormonrefraktaerer ProstatakrebsMitoxantronLebensqualität
DDC-Numbers
610
License
https://rightsstatements.org/vocab/InC-NC/1.0/
URI
https://open.uni-marburg.de/handle/10.17192/z2009.0026
show more
Breitenbach, Kirsten: Multizentrische Therapieoptimierungsstudie zum Einsatz von Docetaxel (Taxotere) und Mitoxantron (Novantron) in der Therapie des hormonrefraktären Prostatakarzinoms. : Philipps-Universität Marburg 2009-03-03. DOI: https://doi.org/10.17192/z2009.0026.

License

item.page.license.under-copyright
This item has been published with the following license: In Copyright